Dynatrace Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Dynatrace Inc. Common Stock trades at $63.48 (market cap $17.66B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B). The key difference: Dynatrace Inc. Common Stock is far larger — about 2.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 8,779,681). Which is the better fit depends on your goals — on Pluang, investors hold Dynatrace Inc. Common Stock for 1 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| DT | IOVA | |
|---|---|---|
Market Cap | $17.66B | $6.04B |
Volume | 8,779,681 | 14,805,993 |
Sector | Technology | Health |
52-Week High | $61.12 | $14.82 |
52-Week Low | $32.36 | $1.81 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $16.71B | $5.97B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Dynatrace provides an observability, security, and automation platform for cloud and IT environments. Its platform integrates data such as logs, metrics, and traces to help organizations monitor digital systems.
Read more on DT →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →